Abstract
Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.
| Original language | English |
|---|---|
| Pages (from-to) | 157-158 |
| Number of pages | 2 |
| Journal | American Journal of Ophthalmology |
| Volume | 138 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jul 2004 |
Fingerprint
ASJC Scopus subject areas
- Ophthalmology
Cite this
Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma. / Parodi, Maurizio Battaglia; Iacono, Pierluigi.
In: American Journal of Ophthalmology, Vol. 138, No. 1, 07.2004, p. 157-158.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Photodynamic therapy with verteporfin for anterior segment neovascularizations in neovascular glaucoma
AU - Parodi, Maurizio Battaglia
AU - Iacono, Pierluigi
PY - 2004/7
Y1 - 2004/7
N2 - Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.
AB - Purpose To evaluate photodynamic therapy (PDT) with verteporfin for iris and angle neovascularization in eyes with neovascular glaucoma. Design Interventional case series. Methods A prospective, noncomparative case series included four patients (four eyes) with neovascular glaucoma. PDT was performed following the parameters of treatment of age-related macular degeneration with photodynamic therapy Study Group (TAP). The laser was directed at the anterior chamber angle and iris surface using a Goldmann three-mirror contact lens. Iris and angle neovascularization were quantified using the number of clock hours involved. Outcome measures were obliteration of neovascularization and decrease of intraocular pressure (IOP). Results One week after PDT, we registered complete obliteration of angle neovascularization and partial occlusion of iris neovascularization. Subsequent reopening of angle neovascularization was detectable at 1 month. Intraocular pressure diminished considerably after 1 week, with a subsequent tendency toward stabilization. Conclusions Photodynamic therapy can be used safely and effectively in the early phases of neovascular glaucoma to achieve angle neovascularization obliteration and IOP reduction.
UR - http://www.scopus.com/inward/record.url?scp=3042784822&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=3042784822&partnerID=8YFLogxK
U2 - 10.1016/j.ajo.2004.02.015
DO - 10.1016/j.ajo.2004.02.015
M3 - Article
C2 - 15234305
AN - SCOPUS:3042784822
VL - 138
SP - 157
EP - 158
JO - American Journal of Ophthalmology
JF - American Journal of Ophthalmology
SN - 0002-9394
IS - 1
ER -